Author Archive: Roy Zwahlen

Roy Zwahlen

Roy is Associate Counsel at BIO and the main contributor for Patently Biotech. He is a lawyer by training, with a background in international and national politics. He grew up in the developing world and believes that innovation can and does solve many of the world’s problems. Because of this, his work focuses on creating a worldwide policy environment that fosters innovation in the biotechnology sector to prevent and cure diseases such as HIV, to increase crop yields to feed more people, and to decrease the harmful effects of industry on the environment. Roy spends his free time keeping up with his three kids, a wife that knows everything (no joke), and serving in his church and broader community. Learn more about Roy from his Linkedin Profile.

Latest Posts

USPTO Requesting Comments on Humanitarian Technologies

In case you missed it, on September 20 the United States Patent Office issued a request for comments on incentivizing humanitarian technologies and licensing through the intellectual property system.  The USPTO is trying to incentivize humanitarian technologies by creating a “fast-track ex parte reexamination voucher pilot program.”  The program will give priority to humanitarian technology patents shortening the review process to six months.  The USPTO also hopes the program will reduce costs for humanitarian technology Read More >

Patently BIOtech  |  2 Comments  |  Email This Post
Tags: , , , , , , , , , , , , ,

Secretary Sebelius speaks at biotech meeting

Secretary Sebelius delivered a speech in California yesterday which recognized the potential of biotechnology to address unmet needs in human health, agriculture and industrial and environmental applications.  In her remarks, Secretary Sebelius stated: “[I]nvesting in each step of the process that starts with basic scientific discovery and ends with the development and provision of better diagnostics, treatments, and preventive strategies to significantly improve health care.  I know I don’t have to tell you that because Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Getting to Market: The Challenges of Technology Transfer

An article about BIO’s recent Technology Transfer Symposium. Getting to Market: The Challenges of Technology Transfer Attendees at special symposium focus on issues of commercializing and licensing biotech discoveries Read the post on BIOtech NOW

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

New Blogger

Patently Biotech has a new writer.  My name is Roy Zwahlen and I am the new Intellectual Property manager at BIO.  I am an attorney and political science undergraduate and fascinated with intellectual property policy.  I am excited about this opportunity to enter the IP blogosphere. My hope is to provide information about BIO’s IP activities including conferences and amicus briefs.  I also hope to reintroduce our IP staff and spotlight our BIO company members.  Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Commends Supreme Court for Expansive View of Patentability in Bilski Decision

The Biotechnology Industry Organization (BIO) released the following statement in reaction to the Supreme Court’s decision to uphold the lower court’s ruling in Bilski v. Kappos.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,